STAT

AUGUST 1, 2024

A decade after Sen. Jack Reed (D-R.I.) authored the Sunscreen Innovation Act , which became law in 2014, Americans are still waiting for newer, more effective sunscreen products due to the Food and Drug Administration’s chronic inaction. Ten years ago, Republicans and Democrats came together to pass this legislation with the promise of overcoming regulatory obstacles and ushering in a new era of sun protection.

326

326

PharmaVoice

AUGUST 1, 2024

From an epic, alternative reality fantasy to a ‘biography of cancer,’ these six reads have stuck with pharma execs as they navigate how to lead.

265

265

STAT

AUGUST 1, 2024

Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy was administered to two more boys and produced high levels of a miniaturized version of the protein needed for muscles to function properly. The updated results from an early study suggest the Regenxbio therapy, called RGX-202, could become the second genetic medicine for Duchenne to reach the market, following the Food and Drug Administration’s approval of Sarepta Therapeutics’ Elevidys in J

315

315

Pharma Times

AUGUST 1, 2024

Combined, ovarian and breast cancer affect over 60,000 women in the UK every year

142

142

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

AUGUST 1, 2024

Jim Wilson, a leading gene therapy researcher who has persisted through the field’s ups and downs , is leaving his longtime academic home at the University of Pennsylvania to found two new companies. Penn is spinning out much of the work of its Gene Therapy Program, where Wilson had served as director, to the two new companies. Most of the program’s employees will be offered roles at the new companies, according to a statement released Wednesday night.

306

306

Pharma Times

AUGUST 1, 2024

The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland

142

142

PharmaVoice

AUGUST 1, 2024

The CEO noted how Pfizer's danuglipron could still be the second oral GLP-1 treatment to enter registrational tests after Lilly's orforglipron.

130

130

STAT

AUGUST 1, 2024

R1 RCM is finally getting taken off the public markets, ending a months-long saga between private equity firms that were trying to take control of the large health care billing and collections company. Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are teaming up to buy R1 , the companies said Thursday. TowerBrook, in a partnership with the Catholic hospital system Ascension, already owns 36% of R1 — which made TowerBrook and Ascension the company’

Hospitals 289

Hospitals 289

The Pharmacist

AUGUST 1, 2024

Community pharmacy has lost much of its ability 'to be a shock absorber' for other parts of primary care, sector leaders have warned as GP collective action begins today. And they have called for 'a new deal' for the community pharmacy sector in addition to resolving government disputes with GPs. Having voted overwhelmingly in favour […] The post GP action bound to have ‘ripple effect’ on already-strained pharmacies appeared first on The Pharmacist.

Community Pharmacies 127

Community Pharmacies 127

STAT

AUGUST 1, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. We’ve got another busy day of earnings and new data readouts. Let’s get straight into it.

Drug Pricing 283

Drug Pricing Drug Development 283

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

The Pharmacist

AUGUST 1, 2024

Primary care networks (PCNs) will be able to recruit GPs under the Additional Roles Reimbursement Scheme (ARRS) for 2024-25, the government has announced. It is hoped the move will enable the recruitment of more than 1,000 GPs. And it will be paid for by £82m 'from the existing department budget', the government said in a […] The post GPs to be added to ARRS this year appeared first on The Pharmacist.

119

119

STAT

AUGUST 1, 2024

Why has it taken so long for the world to get malaria vaccines? What relationship should drug companies have with patient advocates? And who in biotech is having a brat summer? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Andrew Joseph, our Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world’s first malaria vaccines.

Vaccines 283

Vaccines 283

BioPharma Dive

AUGUST 1, 2024

The biotech cited competitive pressure and “very low” expected sales in Europe for its latest guidance cut, which sent shares down by nearly 20%.

119

119

STAT

AUGUST 1, 2024

The Federal Trade Commission presents on Thursday  its interim staff report , “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” It reveals how pharmacy benefit managers intentionally force people onto high-cost, high-rebate drugs. This report comes on the heels of Congress also  putting pressure on PBMs during a hearing that highlighted how these companies undermine patient health and increase drug costs.

Biosimilars 266

Biosimilars 266

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

AUGUST 1, 2024

Changing Faces announces new supplier and digital hires for May and June 2024, including AxoSim, ERS Genomics, Newcells Biotech, SHINE Technologies and more. Stay updated with the latest industry developments.

115

115

STAT

AUGUST 1, 2024

I love the Summer Olympics. Every four years I transform into a huge fan of gymnastics and swimming, probably like all of you. But I also find myself obsessed with some of the nichier sports — handball, rowing, fencing! Go USA! As a reporter who spends most of his time at the intersection of biotech and Wall Street, I know Andrew Left, the short seller indicted by the government on fraud changes.

Drug Pricing 256

Drug Pricing Drug Development 256

pharmaphorum

AUGUST 1, 2024

Bayer files elinzanetant as a non-hormonal treatment for menopausal symptoms, with Astellas' first-to-market Veozah in its sights

115

115

Outsourcing Pharma

AUGUST 1, 2024

The Bateman Horne Center of Excellence (BHC) has established itself as a trusted leader in the clinical care, provider education, patient advocacy, and research of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID.

114

114

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

AUGUST 1, 2024

Stay updated on the latest hiring news and developments from Pfizer, Lilly, Gilead, Epsilogen, and other pharma and biotech companies in May and June 2024 with Changing Faces.

115

115

BioPharma Dive

AUGUST 1, 2024

The job cuts affects 65% of UniQure’s workforce and include the gene therapy developer’s recent sale of a manufacturing plant to Genezen.

113

113

pharmaphorum

AUGUST 1, 2024

Discover how AI is revolutionising the medical and pharmaceutical industries. Learn how to leverage AI for strategic advantage and stay ahead of the competition in this insightful article.

115

115

Pharmaceutical Technology

AUGUST 1, 2024

The UK NICE has recommended BeiGene’s Zanubrutinib for marginal zone lymphoma (MZL) for use on the National Health Service (NHS).

111

111

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

AUGUST 1, 2024

South Africa occupies a pivotal position in the global battle against HIV. As of 2022, it is home to around 7.8 million individuals living with HIV, representing the largest HIV burden in the world. However, it is this very challenge that has placed South Africa at the leading edge of innovative HIV research, with potential ramifications for the millions affected by the disease globally - and that starts with elite controllers.

114

114

The Pharmacist

AUGUST 1, 2024

An overwhelming majority (98.3%) of GPs balloted by the British Medical Association (BMA) have voted in favour of taking 'collective action'. The BMA will therefore be encouraging the profession to pick from a list of actions to take from today (1 August). The proposed action includes limiting daily contacts per clinician to 25 and switching […] The post GPs vote to take 'collective action' appeared first on The Pharmacist.

111

111

pharmaphorum

AUGUST 1, 2024

UK DNA/RNA sequencing specialist Oxford Nanopore raises £80m in a share issue backed with £50m from Novo Holdings

111

111

World Pharma News

AUGUST 1, 2024

Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, announced it will expand its global innovation capabilities with a new research and development (R&D) center and corporate headquarters in San Diego, California.

Immunization 108

Immunization Immunity 108

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 1, 2024

Otsuka Pharma agrees a $1.

111

111

Express Pharma

AUGUST 1, 2024

The U.S. Food and Drug Administration (FDA) India office has announced the appointment of Greg Smith as its new Director. Smith, who previously served as the Deputy Director of the FDA India office, brings over 13 years of experience with the FDA to his new role. Before his tenure in India, Smith was the Director of the Center for Drug Evaluation and Research’s (CDER) Special Projects Staff, where he led a multi-disciplinary team tackling complex scientific, regulatory, legislative, and operatio

Clinical Pharmacology 105

Clinical Pharmacology 105

pharmaphorum

AUGUST 1, 2024

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics.The French pharma company – best known for its COVID-19 jab and recent approval for the world's first chikungunya vaccine Ixchiq – is paying €10 million upfront for a stake in LimmaTech's S4V vaccine candidate, and promising undisclosed regulatory, development and sales-based milestone payments.

Vaccines 105

Vaccines 105

Express Pharma

AUGUST 1, 2024

A research team from the Indian Institute of Technology Kanpur (IITK), led by Prof Arun K. Shukla from the Department of Biological Sciences and Bioengineering, has mapped the complete structure of the Duffy antigen receptor. This receptor, found on the surface of red blood cells and other cells, is a critical target for pathogens such as the malaria parasite Plasmodium vivax and the bacterium Staphylococcus aureus, making it a key focus for developing new drugs to combat these infections.

Drug Development 105

Drug Development 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management